• DNA Construction

DNA makes up the genes which function as blueprints for gene therapy treatments, determining effectiveness, safety, productivity and quality. Synplogen's proprietary DNA synthesis techniques allow for the construction of traditionally challening gene sequences, and is leveraged for the creation of particularly desirable plasmid DNA for viral vectors.

DNA Works

Synplogen's proprietary DNA synthesis technologies allow for the synthesis of part of or even the entire viral genome, and will flexibly provide DNA to meet your vector needs.

Viral DNA engineering Plasmid DNA with partial viral genome
including a therapeutic gene
and tissue-specific promoter.
Vetor plasmid Packaging plasmid Synplogen vector plasmid DNA
and packaging plasmid DNA

Flow

Select "Gene therapy vector preparation/characterization" from the contact form and submit your request details.

Select "Gene therapy vector preparation⁄characterization" from the contact form and submit your request details.

You will be contacted shortly by a Synplogen representative. Please also provide information regarding the nucleic acid and vector.
(An NDA/CDA can be signed if necessary.)

You will be contacted shortly by a Synplogen representative. Please also provide information regarding the nucleic acid and vector.

Synplogen's technical staff and safety committee will determine whether your request can be accepted.

Synplogen's technical staff and safety committee will determine whether your request can be accepted.

If your request can be accepted, you will be provided with an estimate for the services. After receiving confirmation of your order, the requested work will begin.

If your request can be accepted, you will be provided with an estimate for the services. After receiving confirmation of your order, the requested work will begin.

*For joint R&D inquiries and technical questions,
please use the same contact form.

Disclaimers

  • Viral vectors provided by Synplogen may only be used for research and may not be used for clinical or diagnostic applications. If the provided samples are used for anything other than research, Synplogen accepts no liability for any loss or damage that may arise from such use.
  • If viral vectors are necessary for commercial use, please make this clear in your inquiry. A licensing agreement may be necessary.
  • Follow all direction and guidelines for treatment and handling of viral vectors which are provided by law, ordinance (laws governing use of GMOs/LMOs for the protection of biodiversity, local regulations for the appropriate biosafety level/containment measures, etc.) or safety authority (government body or affiliated organization).